These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22488125)

  • 1. Cardiovascular medications in angiogenesis--how to avoid the sting in the tail.
    Ma C; Wang Q; Man Y; Kemmner W
    Int J Cancer; 2012 Sep; 131(6):1249-59. PubMed ID: 22488125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common cardiovascular medications in cancer therapeutics.
    Vaklavas C; Chatzizisis YS; Tsimberidou AM
    Pharmacol Ther; 2011 May; 130(2):177-90. PubMed ID: 21277894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of angiogenesis and angiogenic factors by cardiovascular medications.
    Miura S; Saku K
    Curr Pharm Des; 2007; 13(20):2113-7. PubMed ID: 17627543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein (CRP)-lowering agents.
    Prasad K
    Cardiovasc Drug Rev; 2006; 24(1):33-50. PubMed ID: 16939632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of angiotensin-converting enzyme inhibitors, beta blockers, statins, and aspirin on C-reactive protein levels in outpatients with heart failure.
    Joynt KE; Gattis WA; Hasselblad V; Fuzaylov SY; Serebruany VL; Gurbel PA; Gaulden LH; Felker GM; Whellan DJ; O'Connor CM
    Am J Cardiol; 2004 Mar; 93(6):783-5. PubMed ID: 15019895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New possibilities in the pharmacologic prevention of age-related macular degeneration].
    Fischer T
    Orv Hetil; 2008 Jan; 149(3):121-7. PubMed ID: 18194920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grapefruit-drug interactions.
    Straughan JL
    Cardiovasc J S Afr; 2007; 18(1):39-40. PubMed ID: 17392996
    [No Abstract]   [Full Text] [Related]  

  • 8. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients.
    Naderi SH; Bestwick JP; Wald DS
    Am J Med; 2012 Sep; 125(9):882-7.e1. PubMed ID: 22748400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular therapeutics.
    Shakur R; Cockrum E; Scott D
    Br J Hosp Med (Lond); 2008 Sep; 69(9):M136-40. PubMed ID: 18819300
    [No Abstract]   [Full Text] [Related]  

  • 10. [A new possible strategy for prevention and preventive treatment of age-related macular degeneration resting on recent clinical and pathophysiological observations].
    Fischer T
    Orv Hetil; 2009 Mar; 150(11):503-12. PubMed ID: 19258246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse effects of statins on angiogenesis: new therapeutic avenues.
    Elewa HF; El-Remessy AB; Somanath PR; Fagan SC
    Pharmacotherapy; 2010 Feb; 30(2):169-76. PubMed ID: 20099991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based use of medications in patients with coronary artery disease in a rural Australian community.
    Granmyr J; Ball P; Curran S; Wang L
    Aust J Rural Health; 2007 Aug; 15(4):241-6. PubMed ID: 17617087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential novel pharmacological therapies for myocardial remodelling.
    Landmesser U; Wollert KC; Drexler H
    Cardiovasc Res; 2009 Feb; 81(3):519-27. PubMed ID: 19019834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoring the dysfunctional endothelium.
    Osto E; Coppolino G; Volpe M; Cosentino F
    Curr Pharm Des; 2007; 13(10):1053-68. PubMed ID: 17430168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions with cardiovascular drugs.
    Opie LH
    Curr Probl Cardiol; 1993 Sep; 18(9):531-81. PubMed ID: 7900972
    [No Abstract]   [Full Text] [Related]  

  • 16. Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma.
    Arafat HA; Gong Q; Chipitsyna G; Rizvi A; Saa CT; Yeo CJ
    J Am Coll Surg; 2007 May; 204(5):996-1005; discussion 1005-6. PubMed ID: 17481528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elderly patients undergoing major vascular surgery: risk factors and medication associated with risk reduction.
    Feringa HH; Bax JJ; Karagiannis SE; Noordzij P; van Domburg R; Klein J; Poldermans D
    Arch Gerontol Geriatr; 2009; 48(1):116-20. PubMed ID: 18177954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.
    Blackburn DF; Dobson RT; Blackburn JL; Wilson TW; Stang MR; Semchuk WM
    Can J Cardiol; 2005 May; 21(6):485-8. PubMed ID: 15917876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
    Kuti EL; Baker WL; White CM
    Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.